Substance list · California

Suggested substance list (page 3)

Entries
1015
Version date
2026-07-31

Entries 1001 to 1015 of 1015

SubstanceEnglish nameCAS TypeCategoryThreshold ConditionsValid
4-Vinyl-1-cyclohexene diepoxide (Vinyl cyclohexenedioxide)4-Vinyl-1-cyclohexene diepoxide (Vinyl cyclohexenedioxide)106-87-6 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-07-01
Vinyl cyclohexene dioxide (4-Vinyl-1-cyclohexene diepoxide) [Click here for the basis for the removal of male reproductive endpoint, effective December 20, 2013]Vinyl cyclohexene dioxide (4-Vinyl-1-cyclohexene diepoxide) [Click here for the basis for the removal of male reproductive endpoint, effective December 20, 2013]106-87-6 substancefemale, male µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2008-08-01
Vinyl fluorideVinyl fluoride75-02-5 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1997-05-01
Vinylidene chloride (1,1-Dichloroethylene)Vinylidene chloride (1,1-Dichloroethylene)75-35-4 substancecancer 0.88 µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2017-12-29
Vinyl trichloride (1,1,2-Trichloroethane)Vinyl trichloride (1,1,2-Trichloroethane)79-00-5 substancecancer 10 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-10-01
VismodegibVismodegib879085-55-9 substancedevelopmental, female, male µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 2017-01-27
VoriconazoleVoriconazole137234-62-9; 188416-29-7; 173967-54-9 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2026-07-17
WarfarinWarfarin81-81-2 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-07-01
Welding FumesWelding Fumes othercancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2026-07-17 | CAS column: "---"
Wood dustWood dust othercancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2009-12-18 | CAS column: "---"
2,6-Xylidine (2,6-Dimethylaniline)2,6-Xylidine (2,6-Dimethylaniline)87-62-7 substancecancer 110 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1991-01-01
ZalcitabineZalcitabine7481-89-2 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2009-08-07
Zidovudine (AZT)Zidovudine (AZT)30516-87-1 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2009-12-18
ZileutonZileuton111406-87-2 substancecancer, developmental, female µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 2000-12-22
ZinebZineb12122-67-7 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01 | Delisted: October 29, 1999 until 1999-10-29

Official source

Entries are copied exactly as published. Not legal advice; always check the official text.

2,437 SDSs. None left to chase.

NextSDS processes all 16 sections of every safety data sheet you receive and flags each product with a substance on Suggested substance list.

Get started todaySee how NextSDS works